Efficacy of <scp>MiniMed</scp> ™ <scp>780G</scp> ® on glucose management, sleep quality, and psychological aspects in persons with type 1 diabetes treated with <scp>MiniMed</scp> ™ <scp>770G</scp> ®: A 3‐month prospective single‐center observational

Authors

Satoru Shinoda
Akihiro Kaneko (ORCID: https://orcid.org/0000-0001-8799-2791)
Ryoichi Akamatsu
Masato Akiyama (ORCID: https://orcid.org/0000-0002-1879-5476)
Tadashi Yamakawa (ORCID: https://orcid.org/0000-0001-6329-0939)
Tomoaki Akiyama (ORCID: https://orcid.org/0000-0002-9942-9661)
Kazuki Orime (ORCID: https://orcid.org/0009-0007-2051-1181)
Yasuo Terauchi (ORCID: https://orcid.org/0000-0002-8872-3697)
Arisa Matsuura
Taichi Suezono

Institutions

Yokohama City University Medical Center (JP)
Yokohama City University (JP)

Publication Details

Journal: Journal of Diabetes Investigation
Published: 2025-11-25
DOI: https://doi.org/10.1111/jdi.70198
Primary Topic: Diabetes Management and Research
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Pfizer
AstraZeneca
Sanofi
Takeda Pharmaceutical Company
Kowa Company
Boehringer Ingelheim Japan
Daiichi-Sankyo
Dainippon Sumitomo Pharma
Novo Nordisk
Astellas Pharma
Shionogi
Ono Pharmaceutical
Novartis Pharma
Pfizer Japan
Bayer Yakuhin
Novo Nordisk Pharma
Sanofi K.K.
Daiichi Sankyo Europe

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Efficacy of MiniMed ™ 780G ® on glucose management, sleep quality, and psychological aspects in persons with type 1 diabetes treated with MiniMed ™ 770G ®: A 3‐month prospective single‐center observational

Satoru Shinoda, Akihiro Kaneko, Ryoichi Akamatsu, Masato Akiyama et al.

Nov 25, 2025

Journal of Diabetes Investigation

Diabetes Management and Research

article

Efficacy of MiniMed ™ 780G ® on glucose management, sleep quality, and psychological aspects in persons with type 1 diabetes treated with MiniMed ™ 770G ®: A 3‐month prospective single‐center observational

Satoru Shinoda, Akihiro Kaneko, Ryoichi Akamatsu, Masato Akiyama, Tadashi Yamakawa, Tomoaki Akiyama, Kazuki Orime, Yasuo Terauchi, Arisa Matsuura, Taichi Suezono

November 25, 2025article en

Abstract

No abstract available for this paper.

Journal of Diabetes InvestigationVol. 17(1)

Yokohama City University Medical Center (JP), Yokohama City University (JP)

Pfizer, AstraZeneca, Sanofi, Takeda Pharmaceutical Company, Kowa Company, Boehringer Ingelheim Japan, Daiichi-Sankyo, Dainippon Sumitomo Pharma, Novo Nordisk, Astellas Pharma, Shionogi, Ono Pharmaceutical, Novartis Pharma, Pfizer Japan, Bayer Yakuhin, Novo Nordisk Pharma, Sanofi K.K., Daiichi Sankyo Europe

Openalex Percentile: Top 51%

Diabetes Management and Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Efficacy of <scp>MiniMed</scp> ™ <scp>780G</scp> ® on glucose management, sleep quality, and psychological aspects in persons with type 1 diabetes treated with <scp>MiniMed</scp> ™ <scp>770G</scp> ®: A 3‐month prospective single‐center observational — Satoru Shinoda, Akihiro Kaneko, et al. · Journal of Diabetes Investigation (2025) | TGRS Research Map | TGRS